← Back to medicines
Medicine Image
OTC

Irobest 47 mg+0.5 mg+22.5 mg

NIPRO JMI Pharma Ltd. · Tablet

Generic

Iron Polymaltose Complex + Folic Acid + Zinc Sulfate

Strength47 mg+0.5 mg+22.5 mg
Total Strip6
Strip Size10
Unit Price
3

/ Piece

Order Now

Medicine Description

Detailed scientific information regarding the indications, dosage, potential side effects, and guidelines for use during pregnancy of Irobest or the Iron Polymaltose Complex + Folic Acid + Zinc Sulfate group is provided below. Always consult a specialist physician before taking any medication.

Irobest 47 mg+0.5 mg+22.5 mg | INDICATIONS AND USES

This tablet is indicated for the treatment and prevention of Iron, Folic Acid and Zinc deficiencies.


Irobest 47 mg+0.5 mg+22.5 mg | PHARMACOLOGY

This tablet is the preparation of Iron, Folic Acid and Zinc. In this preparation, Iron is present as Iron (III) Hydroxide Polymaltose Complex, a noble Iron preparation. It contains non-ionic Ferric Iron and Polymaltose in a stable complex. This complex facilitates a controlled absorption of the Iron when it comes in contact with the mucosal cell surface. Due to non-ionic nature, Iron (III) Hydroxide Polymaltose Complex is more stable than conventional Iron form. Folic Acid helps in the proper development of the fetus. Zinc keeps enzymes working and helps to metabolize proteins.


Irobest 47 mg+0.5 mg+22.5 mg | DOSAGE & ADMINISTRATION

One tablet daily. Two tablets may be required a day in severe cases or as directed by the physician.


Irobest 47 mg+0.5 mg+22.5 mg | DRUG INTERACTIONS

Since Iron is complex bound, ionic interaction with foodstuff components (phytates, oxalates, tannin etc.) and concomitant administration of medicaments (tetracyclines, antacids) are unlikely to occur.


Irobest 47 mg+0.5 mg+22.5 mg | SIDE EFFECTS

This tablet is generally well tolerated. However, a few side effects of oral Iron preparations, including nausea, vomiting, constipation or diarrhoea may occur rarely.


Irobest 47 mg+0.5 mg+22.5 mg | USE DURING PREGNANCY AND LACTATION

Use of any drug during the first trimester of pregnancy should be avoided if possible. Thus administration of Iron in the first trimester requires definite evidence of Iron deficiency.


Irobest 47 mg+0.5 mg+22.5 mg | PRECAUTIONS & WARNINGS

As with all Iron preparations, dark coloration of the stool may occur which is without clinical significance.


Irobest 47 mg+0.5 mg+22.5 mg | THERAPEUTIC CLASS

Iron, Vitamin & Mineral Combined preparation


Irobest 47 mg+0.5 mg+22.5 mg | STORAGE CONDITIONS

Keep in a cool & dry place away from light and moisture. Keep out of the reach of children.

⚠ Disclaimer

The information provided on All Samadhan is intended for general informational purposes only and is prepared based on our best practices. It is not a substitute for professional medical advice, diagnosis, or treatment. While we strive to keep the information accurate and up to date, we do not guarantee its completeness or accuracy. The absence of specific information or warnings about any medicine or service should not be considered as an assurance or endorsement by All Samadhan. All Samadhan shall not be held responsible for any consequences arising from the use of this information. We strongly recommend consulting a qualified healthcare professional or physician for any medical concerns, questions, or clarifications.All Samadhan is a digital healthcare software platform operated by MS Genius Experts. We provide technology solutions for pharmacies and healthcare providers; we are not a direct seller or dispenser of prescription medicines

allsomadhan logo

N:B-All Samadhan is a digital healthcare software platform operated by MS Genius Experts. We provide technology solutions for pharmacies and healthcare providers; we are not a direct seller or dispenser of prescription medicines"

Copyright © All Samadhan - Operated by M/S. Genius Experts | All Rights Reserved

DBID

Registration ID: 176322642

Trade License: TRAD/DNCC/040904/2023

Payment Methods
google play storeapple store
Chat with us